Cargando…
Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor Entities
Although immunotherapy plays a significant role in tumor therapy, its efficacy is impaired by an immunosuppressive tumor microenvironment. A molecule that contributes to the protumor microenvironment is the metabolic product lactate. Lactate is produced in large amounts by cancer cells in response t...
Autores principales: | Feichtinger, René G., Lang, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875281/ https://www.ncbi.nlm.nih.gov/pubmed/31781212 http://dx.doi.org/10.1155/2019/2084195 |
Ejemplares similares
-
Targeting Mitochondria in Melanoma
por: Aminzadeh-Gohari, Sepideh, et al.
Publicado: (2020) -
Targeted Metabolomics Identifies Plasma Biomarkers in Mice with Metabolically Heterogeneous Melanoma Xenografts
por: Weber, Daniela D., et al.
Publicado: (2021) -
Overcoming Immune Evasion in Melanoma
por: Eddy, Kevinn, et al.
Publicado: (2020) -
Targeted chemotherapy overcomes drug resistance in melanoma
por: Yue, Jingyin, et al.
Publicado: (2020) -
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
por: Imbert, Caroline, et al.
Publicado: (2020)